Detalles de la búsqueda
1.
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.
Cancer
; 130(11): 2031-2041, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294959
2.
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Oncologist
; 28(7): 644-e564, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37186063
3.
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Oncology
; 99(9): 580-588, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33957633
4.
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.
BMC Cancer
; 21(1): 1094, 2021 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34635061
5.
Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.
Cancer
; 126(22): 4867-4877, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914866
6.
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.
Cancer
; 125(3): 406-415, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30341983
7.
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Natl Compr Canc Netw
; 17(5): 469-477, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31085759
8.
Patient-reported outcomes and quality of life in advanced ALK+ non-small-cell lung cancer trial of brigatinib (ALTA).
Future Oncol
; 15(24): 2841-2855, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31364872
9.
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.
Mol Ther
; 26(5): 1198-1205, 2018 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550074
10.
Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer.
Oncologist
; 23(8): 891-899, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650685
11.
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
Lancet Oncol
; 17(12): 1683-1696, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27836716
12.
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
Lancet Oncol
; 17(11): 1497-1508, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27745820
13.
Systemic therapy for elderly patients with non-small cell lung cancer: Where do we stand in 2019?
Cancer
; 126(5): 931-934, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943149
14.
Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey.
Cancer
; 121(14): 2431-8, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26011157
15.
Warthin's tumors and their relationship to lung cancer.
Cancer Invest
; 33(1): 1-5, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472027
16.
PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer.
Clin Adv Hematol Oncol
; 13(10): 676-83, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27058572
17.
Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.
Cancer Control
; 21(1): 57-62, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24357742
18.
Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey.
Support Care Cancer
; 22(9): 2465-72, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24715092
19.
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors.
Int J Radiat Oncol Biol Phys
; 118(5): 1435-1444, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37866762
20.
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC.
Radiother Oncol
; 190: 110030, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38008414